Cadila Healthcare has informed that it enclosed a copy of press release dated May 26, 2021 titled ‘Zydus and TLC sign agreement to market Liposomal Amphotericin B, a critical drug to treat Black Fungus or Mucormycosis in India’.
The above information is a part of company’s filings submitted to BSE.